Stay updated on Nivolumab Post-HLA Mismatched BMT in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Post-HLA Mismatched BMT in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Post-HLA Mismatched BMT in Sarcoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T02:19:45.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the removal of detailed descriptions of a clinical trial involving Nivolumab for high-risk pediatric sarcoma patients, while adding new identifiers and collaborators related to the study.
    Difference
    49%
    Check dated 2025-04-16T14:19:41.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 10, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.4%
    Check dated 2025-04-09T08:56:07.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:57:17.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The webpage has updated its date references, removing past dates from February 2024 and adding new dates in February 2025.
    Difference
    0.6%
    Check dated 2025-02-17T15:28:13.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:49:38.000Z thumbnail image

Stay in the know with updates to Nivolumab Post-HLA Mismatched BMT in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Post-HLA Mismatched BMT in Sarcoma Clinical Trial page.